Financial Ratios

VINEET LABORATORIES LTD.

NSE : VINEETLABBSE : 543298ISIN CODE : INE505Y01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE55.65-0.11 (-0.2 %)
PREV CLOSE ( ) 55.76
OPEN PRICE ( ) 54.66
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 155
TODAY'S LOW / HIGH ( )54.66 55.65
52 WK LOW / HIGH ( )45.65 88.95
NSE55.65-1.1 (-1.94 %)
PREV CLOSE( ) 56.75
OPEN PRICE ( ) 56.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5350
TODAY'S LOW / HIGH( ) 55.65 56.75
52 WK LOW / HIGH ( )44.65 88.9
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)1.367.201.93-0.270.00
   CEPS(Rs)3.939.393.89-0.270.00
   DPS(Rs)0.001.000.000.000.00
   Book NAV/Share(Rs)36.5436.0328.879.739.12
   Tax Rate(%)38.3028.9656.130.00
Margin Ratios
   Core EBITDA Margin(%)3.616.883.35
   EBIT Margin(%)2.555.982.76
   Pre Tax Margin(%)0.964.891.67
   PAT Margin (%)0.593.470.73
   Cash Profit Margin (%)1.714.531.47
Performance Ratios
   ROA(%)1.015.493.26-2.720.00
   ROE(%)3.7422.1913.18-2.870.00
   ROCE(%)8.6923.1434.06-2.870.00
   Asset Turnover(x)1.701.584.460.000.00
   Sales/Fixed Asset(x)4.935.126.86
   Working Capital/Sales(x)16.3924.0920.790.000.00
Efficiency Ratios
   Fixed Capital/Sales(x)0.200.200.15
   Receivable days61.3575.3364.03
   Inventory Days77.1279.4559.49
   Payable days100.59145.5551.58
Valuation Parameters
   PER(x)30.226.580.000.00
   PCE(x)10.445.050.000.00
   Price/Book(x)1.121.320.000.000.00
   Yield(%)0.002.11
   EV/Net Sales(x)0.320.270.08
   EV/Core EBITDA(x)8.743.872.30-36.58
   EV/EBIT(x)12.574.562.91-36.58
   EV/CE(x)0.590.390.181.020.97
   M Cap / Sales0.180.230.00
Growth Ratio
   Net Sales Growth(%)11.05-21.48
   Core EBITDA Growth(%)-42.1257.610.00
   EBIT Growth(%)-52.6769.990.00
   PAT Growth(%)-81.13272.890.00
   EPS Growth(%)-81.13272.90813.16
Financial Stability Ratios
   Total Debt/Equity(x)0.920.800.470.000.00
   Current Ratio(x)1.171.081.16998.2550.99
   Quick Ratio(x)0.550.620.63998.2550.99
   Interest Cover(x)1.605.482.52
   Total Debt/Mcap(x)0.820.61

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.